Arkolith/Insider Trading/LGND/Form 4

Sabba Stephen L

DirectorLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Mar 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$208K
Net Open-Market Flow
-$208K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)1K$207.87$208K33K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-034308) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML